[
    [
        {
            "time": "2023-04-15",
            "original_text": "Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly",
            "features": {
                "keywords": [
                    "Q1",
                    "Earnings",
                    "Exxon",
                    "Oracle",
                    "Eli Lilly"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "energy",
                    "technology",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Q1 Earnings Scorecard and Analyst Reports for Exxon, Oracle & Eli Lilly",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-16",
            "original_text": "Can Lilly (LLY) Deliver a Beat in Coronavirus-Hit Q1 Earnings?",
            "features": {
                "keywords": [
                    "Lilly",
                    "Beat",
                    "Coronavirus",
                    "Q1 Earnings"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Can Lilly (LLY) Deliver a Beat in Coronavirus-Hit Q1 Earnings?",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-17",
            "original_text": "Lilly Receives Downgrade to Neutral From Buy at UBS",
            "features": {
                "keywords": [
                    "Lilly",
                    "Downgrade",
                    "Neutral",
                    "UBS"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Lilly Receives Downgrade to Neutral From Buy at UBS",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-04-18",
            "original_text": "The Zacks Analyst Blog Highlights: Netflix, Silgan, Citrix Systems, Eli Lilly and FirstEnergy",
            "features": {
                "keywords": [
                    "Zacks",
                    "Analyst",
                    "Netflix",
                    "Silgan",
                    "Citrix Systems",
                    "Eli Lilly",
                    "FirstEnergy"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "entertainment",
                    "industrial",
                    "technology",
                    "healthcare",
                    "utilities"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The Zacks Analyst Blog Highlights: Netflix, Silgan, Citrix Systems, Eli Lilly and FirstEnergy",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-04-19",
            "original_text": "Eli Lilly Stock Has Gone as High as It Can Go for Now, Analyst Says",
            "features": {
                "keywords": [
                    "Eli Lilly",
                    "Stock",
                    "High",
                    "Analyst"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Eli Lilly Stock Has Gone as High as It Can Go for Now, Analyst Says",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-04-20",
            "original_text": "Buy 5 Top Health Care Stocks Ahead of Q1 Earnings Results",
            "features": {
                "keywords": [
                    "Buy",
                    "Health Care",
                    "Stocks",
                    "Q1 Earnings"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Buy 5 Top Health Care Stocks Ahead of Q1 Earnings Results",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]